Obsidian Therapeutics, Inc.
NASDAQOBX has gone from a year-to-date standout to the week's most dramatic reversal in biotech — down 35% in five sessions after a 2026 run that had briefly taken it up more than 340%. The borrow market tells a story of rapid repositioning. At the start of the week, borrow availability was tight, with shares available at barely 106% of short interest — the tightest level recorded in the…
Snapshot as of 16 Aug 2026
OBX has gone from a year-to-date standout to the week's most dramatic reversal in biotech — down 35% in five sessions after a 2026 run that had briefly taken it up more than 340%. The borrow market tells a story of…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OBX — free to start on ORTEX.
Sign up for free →Open OBX on ORTEX